Electromedical Technologies, Inc.
EMED · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $990 | $289 | $286 | $378 |
| - Cash | $15 | $1 | $0 | $10 |
| + Debt | $779 | $782 | $1,177 | $1,575 |
| Enterprise Value | $1,754 | $1,070 | $1,463 | $1,943 |
| Revenue | $8 | $7 | $15 | $18 |
| % Growth | 8.9% | -50.8% | -19.1% | – |
| Gross Profit | -$8 | -$7 | -$2 | -$4 |
| % Margin | -104.1% | -102.1% | -15.8% | -24.2% |
| EBITDA | -$359 | -$92 | -$241 | $108 |
| % Margin | -4,617.2% | -1,280.7% | -1,660.6% | 604.1% |
| Net Income | -$649 | -$108 | -$292 | $38 |
| % Margin | -8,340.1% | -1,507.2% | -2,010.7% | 210.3% |
| EPS Diluted | 0 | 0 | -0 | 0.001 |
| % Growth | – | 100% | -125% | – |
| Operating Cash Flow | -$247 | -$34 | $0 | -$28 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$247 | -$34 | $0 | -$28 |